These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9044559)

  • 1. [The role of the analytical laboratory in the monitoring of clinical studies].
    Pacifici R; Pellegrini M; Bacosi A; Di Carlo S; Zuccaro P
    Boll Chim Farm; 1996 Feb; 135(2):124-6. PubMed ID: 9044559
    [No Abstract]   [Full Text] [Related]  

  • 2. Pitfalls and errors in drug monitoring: analytical aspects.
    Hassan FM; Pesce AJ; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1983 Oct; 5(8):567-73. PubMed ID: 6664157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and pharmacokinetics in children and the elderly.
    Pelkonen O
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):147-8. PubMed ID: 17428146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Getting the dose right": facts, a blueprint, and encouragements.
    Peck CC; Cross JT
    Clin Pharmacol Ther; 2007 Jul; 82(1):12-4. PubMed ID: 17571068
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioanalysis in China.
    Zhong D
    Bioanalysis; 2010 Feb; 2(2):153-6. PubMed ID: 21083295
    [No Abstract]   [Full Text] [Related]  

  • 6. Less is more: the human microdosing concept.
    Garner RC
    Drug Discov Today; 2005 Apr; 10(7):449-51. PubMed ID: 15809185
    [No Abstract]   [Full Text] [Related]  

  • 7. Skin biopsies for the measurement of clinical pharmacodynamic biomarkers.
    Phillips RL; Sachs AB
    Curr Opin Biotechnol; 2005 Dec; 16(6):687-90. PubMed ID: 16257524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Harmonization procedures directed toward clinical trials in laboratory medicine at the National Cancer Center Hospital].
    Ozeki M; Shioya K; Furuta K
    Rinsho Byori; 2009 Sep; 57(9):827-33. PubMed ID: 19860207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American College of Clinical Pharmacology position statement on the use of microdosing in the drug development process.
    Bertino JS; Greenberg HE; Reed MD;
    J Clin Pharmacol; 2007 Apr; 47(4):418-22. PubMed ID: 17389550
    [No Abstract]   [Full Text] [Related]  

  • 10. The pivotal role of drug metabolism and pharmacokinetics in the discovery and development of new medicines.
    Alavijeh MS; Palmer AM
    IDrugs; 2004 Aug; 7(8):755-63. PubMed ID: 15334309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary on ACCP position statement on the use of microdosing in the drug development process.
    Rowland M
    J Clin Pharmacol; 2007 Dec; 47(12):1595-6; author reply 1597-8. PubMed ID: 18048576
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges for drug studies in children: CYP3A phenotyping as example.
    de Wildt SN; Ito S; Koren G
    Drug Discov Today; 2009 Jan; 14(1-2):6-15. PubMed ID: 18721895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs and the clinical laboratory.
    Sannella JJ
    J Tenn Med Assoc; 1975 Sep; 68(9):715. PubMed ID: 1186217
    [No Abstract]   [Full Text] [Related]  

  • 14. An integrated, multidisciplinary approach for drug safety assessment.
    Li AP
    Drug Discov Today; 2004 Aug; 9(16):687-93. PubMed ID: 15341779
    [No Abstract]   [Full Text] [Related]  

  • 15. [Harmonization of testing drugs for bioequivalence: problems and possible solutions].
    Zherdev VP; Kolyvanov GB; Litvin AA; Sariev AK
    Eksp Klin Farmakol; 2003; 66(2):60-4. PubMed ID: 12962051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmaceutical industry--to whom is it accountable?
    Hayes TA
    N Engl J Med; 2000 Nov; 343(19):1416; discussion 1417. PubMed ID: 11183881
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of the laboratory in treatment of the poisoned patient.
    Snyder JW; Vlasses PH
    Arch Intern Med; 1988 Feb; 148(2):279-80. PubMed ID: 3341835
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug load in clinical trials: a neglected factor.
    Deckers CL; Hekster YA; Keyser A; Meinardi H; Renier WO
    Clin Pharmacol Ther; 1997 Dec; 62(6):592-5. PubMed ID: 9433387
    [No Abstract]   [Full Text] [Related]  

  • 19. A seat at the table: the benefits of integrating bioanalytical sciences into development project teams.
    Aubry AF
    Bioanalysis; 2014 May; 6(10):1291-3. PubMed ID: 24958113
    [No Abstract]   [Full Text] [Related]  

  • 20. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
    Tolonen A; Turpeinen M; Pelkonen O
    Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.